Randomized, Double-Blinded, Phase 2 Trial of WR 279,396 (Paromomycin and Gentamicin) for Cutaneous Leishmaniasis in Panama

In this randomized, double-blinded Phase 2 trial, 30 patients with Leishmania panamensis cutaneous leishmaniasis were randomly allocated (1:1) to receive once daily topical treatment with WR 279,396 (15% paromomycin + 0.5% gentamicin) or Paromomycin Alone (15% paromomycin) for 20 days. The index les...

Descripción completa

Detalles Bibliográficos
Autores principales: Sosa, Néstor, Capitán, Zeuz, Nieto, Javier, Nieto, Melissa, Calzada, José, Paz, Hector, Spadafora, Carmenza, Kreishman-Deitrick, Mara, Kopydlowski, Karen, Ullman, Diane, McCarthy, William F., Ransom, Janet, Berman, Jonathan, Scott, Charles, Grogl, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771300/
https://www.ncbi.nlm.nih.gov/pubmed/23857024
http://dx.doi.org/10.4269/ajtmh.12-0736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771300/
https://www.ncbi.nlm.nih.gov/pubmed/23857024
http://dx.doi.org/10.4269/ajtmh.12-0736

Ejemplares similares